I'm sure that there are surgeons reluctant to try it and would rather spend 4 hours doing a rotational flap with the risk of ischemic necrosis at the end. But as more case studies like this get published and word spreads, BTM will perhaps even become the first choice in many cases.
- Forums
- ASX - By Stock
- PNV
- The Clinicians Speak
The Clinicians Speak, page-668
-
- There are more pages in this discussion • 366 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.55 |
Change
-0.025(0.97%) |
Mkt cap ! $1.787B |
Open | High | Low | Value | Volume |
$2.60 | $2.60 | $2.53 | $1.147M | 446.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 15881 | $2.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.55 | 10889 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 15881 | 2.540 |
16 | 42097 | 2.530 |
10 | 33591 | 2.520 |
12 | 53631 | 2.510 |
11 | 23040 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.550 | 10889 | 16 |
2.560 | 44045 | 18 |
2.570 | 35852 | 19 |
2.580 | 61746 | 13 |
2.590 | 41991 | 11 |
Last trade - 11.49am 15/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online